Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aging, disease and nerve cell death]

Y Agid1

  • 1INSERM U 289, Hôpital de La Salpêtrière, Paris.

Bulletin De L'Academie Nationale De Medecine
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Apoptosis, or programmed cell death, is a key process in neurodegeneration. This study found apoptosis in dopaminergic neurons of Parkinson's disease patients, suggesting it may be the final step in their degeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study.

Neuropsychologia·2000
Same author

Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG).

European journal of human genetics : EJHG·1999
Same author

Levodopa in the treatment of Parkinson's disease: a consensus meeting.

Movement disorders : official journal of the Movement Disorder Society·1999
Same author

Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.

Neurology·1999
Same author

Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum.

The Journal of comparative neurology·1999
Same author

The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society·1999
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Area of Science:

  • Neurobiology
  • Cell Biology
  • Biochemistry

Context:

  • Apoptosis, or programmed cell death, involves active cellular self-destruction.
  • Homologies exist between nematode cell death proteins (CED-3, CED-9) and vertebrate proteins (Bcl-2, ICE).
  • Initiating factors for apoptosis include genotoxicity, growth factor deprivation, and cytokines like TNF alpha.

Purpose:

  • To investigate the role of apoptosis in Parkinson's disease by examining dopaminergic neurons.
  • To differentiate biochemical abnormalities in aging, neurodegeneration, and normal nerve cell death.
  • To identify morphological and biochemical signs of apoptosis in the substantia nigra of Parkinson's patients and controls.

Summary:

  • Histopathological signs of apoptosis were observed in approximately 5% of dopaminergic neurons in Parkinson's patients.

Related Experiment Videos

  • TNF alpha receptors and bcl-2 gene expression were detected in these dopaminergic neurons.
  • Apoptosis may represent the terminal stage of dopaminergic neuronal degeneration in Parkinson's disease.

    • Impact:

    • Findings suggest distinct mechanisms for neuronal senescence, neurodegeneration, and apoptosis.
    • Understanding these mechanisms could inform neurobiologists and pharmacologists.
    • This research highlights apoptosis as a potential therapeutic target in Parkinson's disease and other neurodegenerative disorders.